Research output per year
Research output per year
Fingerprint
Dive into the research topics where Marthe Paats is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer
de Leeuw, S. P., Pruis, M. A., Sikkema, B. J., Mohseni, M., Veerman, G. D. M., Paats, M. S., Dumoulin, D. W., Smit, E. F., Schols, A. M. W. J., Mathijssen, R. H. J., van Rossum, E. F. C. & Dingemans, A-M. C., 29 Mar 2023, (E-pub ahead of print) In: Journal of Thoracic Oncology.Research output: Contribution to journal › Article › Academic › peer-review
-
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up
Pruis, M. A., Veerman, G. D. M., Hassing, H. C., Lanser, D. A. C., Paats, M. S., van Schaik, R. H. N., Mathijssen, R. H. J., Manintveld, O. & Dingemans, A. M. C., Feb 2023, In: JACC: CardioOncology. 5, 1, p. 102-113 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)8 Downloads (Pure) -
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)
Meertens, M., Muntinghe-Wagenaar, M. B., Sikkema, B. J., Lopez-Yurda, M., Retèl, V. P., Paats, M. S., Ter Heine, R., Schuuring, E., Timens, W., Touw, D. J., van Boven, J. F. M., de Langen, A. J., Hashemi, S. M. S., Hendriks, L. E. L., Croes, S., van den Heuvel, M. M., Dingemans, A-M. C., Mathijssen, R. H. J., Smit, E. F., Huitema, A. D. R., & 2 others, 9 Mar 2023, In: Frontiers in Oncology. 13, 1136221.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)3 Downloads (Pure) -
Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer
Veerman, G. D. M., Hurkmans, D. P., Paats, M. S., Oomen-de Hoop, E., van der Leest, C. H., van Thiel, E. R. E., Aerts, J. G. J. V., van Leeuwen, R. W., Dingemans, A. M. C. & Mathijssen, R. H. J., Nov 2022, In: Biomedicine and Pharmacotherapy. 155, 113695.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile12 Downloads (Pure) -
Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course
Miedema, J., Schreurs, M., van der Sar – van der Brugge, S., Paats, M., Baart, S., Bakker, M., Hoek, R., Dik, W. A., Endeman, H., Van Der Velden, V., van Gammeren, A., Ermens, A., Aerts, J. G. & Thüsen, J. V. D., 13 May 2021, In: Frontiers in Immunology. 12, 684142.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile13 Citations (Scopus)13 Downloads (Pure)